Cannabidiol
"Cannabidiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compound isolated from Cannabis sativa extract.
Descriptor ID |
D002185
|
MeSH Number(s) |
D02.455.849.090.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cannabidiol".
Below are MeSH descriptors whose meaning is more specific than "Cannabidiol".
This graph shows the total number of publications written about "Cannabidiol" by people in this website by year, and whether "Cannabidiol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 0 | 1 | 1 | 2016 | 1 | 0 | 1 | 2019 | 3 | 1 | 4 | 2020 | 3 | 1 | 4 | 2021 | 6 | 1 | 7 | 2022 | 7 | 0 | 7 | 2023 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cannabidiol" by people in Profiles.
-
Swenson KS, Gomez Wulschner LE, Hoelscher VM, Folts L, Korth KM, Oh WC, Bates EA. Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, problem-solving, and prefrontal cortex excitability. Mol Psychiatry. 2023 Aug; 28(8):3397-3413.
-
Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and ?9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms. Mov Disord. 2023 07; 38(7):1341-1346.
-
Moore BF, Salmons KA, Hoyt AT, Swenson KS, Bates EA, Sauder KA, Shapiro ALB, Wilkening G, Kinney GL, Neophytou AM, Sempio C, Klawitter J, Christians U, Dabelea D. Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start Study. Int J Environ Res Public Health. 2023 03 10; 20(6).
-
Berry-Kravis E, Hagerman R, Budimirovic D, Erickson C, Heussler H, Tartaglia N, Cohen J, Tassone F, Dobbins T, Merikle E, Sebree T, Tich N, Palumbo JM, O'Quinn S. A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). J Neurodev Disord. 2022 11 25; 14(1):56.
-
Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of Cannabidiol in the Management of Insomnia: A Systematic Review. Cannabis Cannabinoid Res. 2023 04; 8(2):213-229.
-
Lopez JC, Pare JR, Blackmer AB, Orth LE. Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications. J Pediatr Health Care. 2022 Sep-Oct; 36(5):479-488.
-
Rundle CW, Rietcheck HR, Maghfour J, Dercon S, Fernandez J, Lio P, Dellavalle RP, Fujita M, Yardley H. Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12- O -Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in Mice. Dermatitis. 2022 Jul-Aug 01; 33(4):277-281.
-
Guard SE, Chapnick DA, Poss ZC, Ebmeier CC, Jacobsen J, Nemkov T, Ball KA, Webb KJ, Simpson HL, Coleman S, Bunker E, Ramirez A, Reisz JA, Sievers R, Stowell MHB, D'Alessandro A, Liu X, Old WM. Multiomic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell Lines. Mol Cell Proteomics. 2022 Oct; 21(10):100262.
-
Sempio C, Almaraz-Quinones N, Jackson M, Zhao W, Wang GS, Liu Y, Leehey M, Knupp K, Klawitter J, Christians U, Klawitter J. Simultaneous Quantification of 17 Cannabinoids by LC-MS-MS in Human Plasma. J Anal Toxicol. 2022 Apr 21; 46(4):383-392.
-
Miller OS, Elder EJ, Jones KJ, Gidal BE. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners. Epilepsy Behav. 2022 02; 127:108514.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|